Are asylum seekers, refugees and foreign migrants considered in the COVID-19 vaccine discourse?
Are asylum seekers, refugees and foreign migrants considered in the COVID-19 vaccine discourse?
复制标题
DOI:
10.1136/bmjgh-2020-004085
复制
发表时间:
2020-11
影响因子:
8.1
通讯作者:
Mukumbang FC
中科院分区:
文献类型:
--
作者:
Mukumbang FC
INTRODUCTION There is a propitious belief that a potent vaccine against the SARS-COV-2 virus is a panacea for the COVID-19 pandemic. The need for a potent vaccine is heightened as many nations are finding it counterproductive to sustain national lockdowns and individuals are becoming complacent with their hygiene and social (physical) distancing practices. Currently, there are more than 100 COVID-19 vaccine candidates under development, with a number of these in the human trial phase. It is suggested that the introduction of a COVID-19 vaccine will prevent the loss of US $375 billion to the global economy every month. 1 There is a scientific consensus that the only way toeradicate the pandemic will be to vaccinate all people worldwide. 2 To this end, the United Nations General Assembly calls for ‘the rapid scaling up of manufacturing and establishment of supply chains that promote and ensure fair, transparent, equitable, efficient and timely access to drugs and future COVID-19 vaccines’. 3 Consequently, at this moment, global health and political discourse related to the COVID-19 pandemic are dominated by COVID-19 vaccine development, production and distribution. Regarding the vaccine distribution, there are many proposals on the table for the ethical distribution between countries. 4 There is a continuum of positions regarding the acquisition of COVID-19 vaccines. To one extreme is vaccine nationalism, whereby governments sign agreements with pharmaceutical manufacturers to supply their populations with vaccines ahead of the vaccines becoming available for other countries. 5 On the other extreme is the global access to COVID-19 vaccine through fair distribution underpinned by the notion of global public good—impacting residents of more than one country, even if not necessarily the whole world. 6 Many countries display a mix of both, first trying to secure vaccines for their populations but also doing their share in terms of helping to ensure that vaccines are available to the most vulnerable everywhere. The Access to COVID-19 Tools Accelerator, a global collaboration, seeks to accelerate the development, production and equitable access to COVID-19 tests, treatments and vaccines, 1 with the vaccine pillar being managed through the COVID-19 Vaccines Global Access (COVAX) Facility. Through the COVAX platform, countries are encouraged to sign up to a deal that will ensure that they receive a portion of the anticipated 2
登录
查看更多内容
DOI:
10.1126/science.abe2803
发表时间:
2020-09-11
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Emanuel EJ;Persad G;Kern A;Buchanan A;Fabre C;Halliday D;Heath J;Herzog L;Leland RJ;Lemango ET;Luna F;McCoy MS;Norheim OF;Ottersen T;Schaefer GO;Tan KC;Wellman CH;Wolff J;Richardson HS
通讯作者:
Richardson HS
DOI:
10.1016/s2666-7568(20)30003-9
发表时间:
2020-10
期刊:
The lancet. Healthy longevity
影响因子:
--
作者:
Yunus M;Donaldson C;Perron JL
通讯作者:
Perron JL
影响因子:
4.8
作者:
Mukumbang, Ferdinand C.;Ambe, Anthony N.;Adebiyi, Babatope O.
通讯作者:
Adebiyi, Babatope O.
影响因子:
9.5
作者:
Choudhari, Ranjana
通讯作者:
Choudhari, Ranjana
DOI:
10.4103/0976-9668.136141
发表时间:
2014-07-01
期刊:
Journal of natural science, biology, and medicine
影响因子:
--
作者:
Virupaksha, H G;Kumar, Ashok;Nirmala, Bergai Parthsarathy
通讯作者:
Nirmala, Bergai Parthsarathy